Document Detail


Clozapine-induced neuroleptic malignant syndrome: review and report of new cases.
MedLine Citation:
PMID:  8830069     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The published case reports of clozapine-induced neuroleptic malignant syndrome (NMS) are reviewed, to which the authors add three, and possibly four, new cases seen in Australia, occurring in and estimated 1,250 patients exposed to the drug. The review suggests that typical NMS does occur with clozapine and that its incidence may be as common as with the classic neuroleptics. The features of clozapine-induced NMS may be somewhat different, with fewer extrapyramidal side effects and a lower rise in creatine kinase levels. The occurrence of NMS with clozapine raises important issues with regard to our understanding of the pathophysiology of the syndrome.
Authors:
P Sachdev; J Kruk; M Kneebone; D Kissane
Related Documents :
9022659 - Syndrome of inappropriate secretion of antidiuretic hormone in two elderly women with e...
7567439 - Longitudinal melanonychia induced by hydroxyurea: four case reports and review of the l...
19495809 - Saliva substitutes for the treatment of radiation-induced xerostomia--a review.
7796069 - Generalized nonconvulsive status epilepticus after electroconvulsive therapy.
23031179 - Extensive bilateral arteriovenous malformations of the mandible successfully controlled...
16963229 - Amisulpride-induced tardive dyskinesia.
11777019 - A multiple sclerosis cluster associated with a small, north-central illinois community.
23412719 - Shellfish-borne viral outbreaks: a systematic review.
18457699 - Immunologic reactions and endodontics: an online study guide.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Journal of clinical psychopharmacology     Volume:  15     ISSN:  0271-0749     ISO Abbreviation:  J Clin Psychopharmacol     Publication Date:  1995 Oct 
Date Detail:
Created Date:  1996-10-16     Completed Date:  1996-10-16     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8109496     Medline TA:  J Clin Psychopharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  365-71     Citation Subset:  IM    
Affiliation:
Neuropsychiatric Institute, Prince Henry Hospital, Sydney, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Antipsychotic Agents / adverse effects*,  therapeutic use
Australia
Child
Clozapine / adverse effects*,  therapeutic use
Creatine Kinase / blood
Female
Humans
Male
Middle Aged
Neuroleptic Malignant Syndrome / etiology*
Neurologic Examination / drug effects
Schizophrenia / drug therapy*
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 5786-21-0/Clozapine; EC 2.7.3.2/Creatine Kinase
Comments/Corrections
Comment In:
J Clin Psychopharmacol. 1997 Jun;17(3):233-4   [PMID:  9169977 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clonidine plus haloperidol in the treatment of schizophrenia/psychosis.
Next Document:  Ethical problems raised by the current French practice of therapeutic abortions. Part I: prospective...